Inventor · disambiguated record
Isabelle Dussault
Also filed as: DUSSAULT ISABELLE
0 granted patents·15 pending applications·0 citations·filing 2001–2021
Top patents by PatentIndex Score
15 records- 0156US2011104161A1Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancerBURGESS TERESA L·Filed 2009·Application pending·0 cites
- 0255US2021196822A1Treatment of triple negative breast cancer with targeted tgf-b inhibitionMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 0354US2005004165A1Composition and method for modulating BAR/FXR receptor activityFiled 2004·Application pending·0 cites
- 0453US2014243339A1Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Application pending·0 cites
- 0552US2004019027A1Method of treating cerebrotendinous xanthomatosisFiled 2003·Application pending·0 cites
- 0649US2002137663A1The anti-neoplastic agent ET-743 inhibits trans activation by SXRFiled 2001·Application pending·0 cites
- 0748US2005037404A1Methods of modulating drug clearance mechanisms by altering SXR activityHOPE CITY·Filed 2004·Application pending·0 cites
- 0848US2003144360A1Composition and method for modulating BAR/FXR receptor activityALLERGAN SALES INC·Filed 2002·Application pending·0 cites
- 0947US2021113656A1Treatment of stage iii nsclc and mitigation of pathological conditions associated with the treatmentMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1047US2002022599A1Methods of modulating drug clearance mechanisms by altering SXR activityFiled 2001·Application pending·0 cites
- 1147US2021214446A1Dosing regimens for targeted tgf-b inhibition for use in treating biliary tract cancerMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1245US2021061899A1Dosing regimens for targeted tgf-b inhibition for use in treating cancer in treatment naïve subjectsMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1345US2021115145A1Combination therapy with targeted tgf-b inhibition for treatment of advanced non-small cell lung cancerMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1439US2019330375A1Dosing regimens and dosage forms for targeted tgf-b inhibitionMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
- 1536US2002061836A1Methods for altering SXR activation using peptide mimetic HIV protease inhibitor SXR ligandsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Isabelle Dussault files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →